Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results
Data from Phase 2 BESTOW trial demonstrated a favorable safety and tolerability profile, substantially reducing the metabolic, neurologic, and cardiovascular toxicities commonly associated with tacrol ...
Data from Phase 2 BESTOW trial demonstrated a favorable safety and tolerability profile, substantially reducing the metabolic, neurologic, and cardiovascular toxicities commonly associated with tacrol ...
Expert Consumers has officially ranked QuickBooks as the #1 financial management software for 2025, recognizing ...
CFO Naveen Kumar Amar explains how he plans to strengthen SS Innovations’ financial framework and support its global healthcare impact.
HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing ...
Mumbai: Central banks are unique in two ways, first, they are public policy institutions that operate without any profit ...
Operator: Greetings, and welcome to the Paysafe Third Quarter 2025 Earnings Conference Call and Webcast. At this time, all ...
Predictive Oncology is headquartered in Pittsburgh, PA.
Across New York and beyond, companies are discovering that this sweeping act is opening doors to growth, innovation and ...
The Oncology Institute, Inc. (NASDAQ: TOI) Q3 2025 Earnings Call Transcript November 13, 2025 The Oncology Institute, Inc.
Q1 2026 Earnings Call November 14, 2025 8:30 AM ESTCompany ParticipantsJohn Schaible - Executive ChairmanDavid Ridenhour ...
BIO-key International, Inc. ( BKYI) Q3 2025 Earnings Call November 14, 2025 10:00 AM EST Good morning, everyone. Thank you for standing by, and welcome to BIO-key International's Third Quarter 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback